STOCK TITAN

Cibus (CBUS) Stock News, Jun 1-15, 2023

CBUS Nasdaq

Cibus, Inc. develops and licenses gene-edited plant traits for seed companies rather than selling seed directly. Its proprietary high-throughput gene-editing technologies, including the Rapid Trait Development System™, are used to create productivity traits for major row crops that address yield, weed, disease, insect, nutrient-use and climate-related farming challenges.

Company news commonly covers rice herbicide-tolerance and weed-management traits, seed-company and research partnerships, sustainable ingredients work, regulatory developments for precision breeding, financial results, board composition, shareholder voting matters and capital-structure actions. Updates also describe how Cibus seeks royalty revenue from licensed traits included in customers' seed products.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.78%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.78%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.82%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.3%
Tags

FAQ

What is the current stock price of Cibus (CBUS)?

Cibus (CBUS) last closed at $1.41.

What is the market cap of Cibus (CBUS)?

The market cap of Cibus (CBUS) is approximately $107.8M.